• Find an Expert
  • Search iconSearch
  • Menu
  • Help
  • Report an issue

Contact


Email

abehren@unimelb.edu.au

Credentials


Position

Medicine - Austin Health

Dr. Andreas Behren

Honorary
Medicine - Austin Health

58 Scholarly works
1 Projects

HIGHLIGHTS

  • 2020

    Journal article

    Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
    DOI: 10.1158/2326-6066.CIR-19-0894
  • 2020

    Journal article

    Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial
    DOI: 10.1001/jamaoncol.2020.2814
  • 2020

    Journal article

    Methylation dependent gold adsorption behaviour identifies cancer derived extracellular vesicular DNA
    DOI: 10.1039/d0nh00258e
  • 2020

    Journal article

    Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
    DOI: 10.1038/s41598-020-70774-9
  • 2020

    Conference Proceedings

    Butyrophilin molecules govern gamma delta T cell reactivity against phosphoantigens
  • 2020

    Research Grant

    RECOGNITION OF PHOSPHOANTIGEN BY GAMMA-DELTA T CELLS
  • 2013

    Journal article

    BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
    DOI: 10.1158/1078-0432.CCR-13-0398
Andreas Behren

RECENT SCHOLARLY WORKS

  • 2020

    Journal article

    A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response
    DOI: 10.1016/j.jid.2019.07.725
  • 2020

    Journal article

    Butyrophilin 2A1 is essential for phosphoantigen reactivity by gamma delta T cells
    DOI: 10.1126/science.aay5516
  • 2020

    Journal article

    Pan-cancer analysis of whole genomes
    DOI: 10.1038/s41586-020-1969-6
  • 2020

    Journal article

    Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma
    DOI: 10.1126/sciadv.aax3223
  • 2020

    Journal article

    Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
    DOI: 10.1136/jitc-2019-000410
  • 2020

    Journal article

    A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia
    DOI: 10.2147/DDDT.S243787
  • 2019

    Journal article

    A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
    DOI: 10.1158/2326-6066.CIR-18-0500
  • 2019

    Conference Proceedings

    A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.
    DOI: 10.1200/JCO.2019.37.15_suppl.2570

UNIVERSITY SEARCH

›  

Current students

›  

Staff

›  

Alumni

  

Faculties & graduate schools

  

Library

  

Contact us

  

Maps

  

Support the campaign

  

Jobs

facebookIcontwitterIconlinkedinIcon


Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511

ABN: 84 002 705 224

CRICOS Provider Code:
00116K ( visa information)

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

STUDY AT MELBOURNE

›  Find a course

›  Admissions, fees & applications

›  International students

›  Campus tour

›  Connect with us

›  Accommodation

ABOUT US

›  Strategy and leadership

›  Tradition of excellence

›  International connections

›  Campuses and facilities

›  Structure and governance

›  Policy and publications

›  Careers at Melbourne

›  Supplying to the University

CONTACT & MAPS

›  Enquiries

›  Media

›  Find an expert

›  Campus maps

›  Traffic, parking & bicycles

›  Find a staff member

ALUMNI & FRIENDS

›  Benefits & services

›  Give

›  Volunteer

›  3010: alumni magazine

RESEARCH

›  Research institute

›  Find an expert or supervisor

›  Graduate researchers

›  Pursuit: our research showcase

ENGAGEMENT

›  Events

›  Sports facilities

›  Shop

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated.